What is NDC 62332-241?

62332-241 is the product NDC for Ticagrelor, Ticagrelor 90 mg/1 tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ticagrelor?

51 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ticagrelor NDC 62332-241 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-241Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0241Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-241-30	6233202413062332024130	30 TABLET, FILM COATED in 1 BOTTLE (62332-241-30)Marketed from May 1, 2025
62332-241-31	6233202413162332024131	100 TABLET, FILM COATED in 1 BOTTLE (62332-241-31)Marketed from May 1, 2025
62332-241-60	6233202416062332024160	60 TABLET, FILM COATED in 1 BOTTLE (62332-241-60)Marketed from May 1, 2025
62332-241-91	6233202419162332024191	1000 TABLET, FILM COATED in 1 BOTTLE (62332-241-91)Marketed from May 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ticagrelor
Generic name (nonproprietary): ticagrelor
Active ingredients: Ticagrelor — 90 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.NDC labeler code 62332
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208576
Marketing start: May 1, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)P-Glycoprotein Inhibitors (Mechanism)P2Y12 Receptor Antagonists (Mechanism)
Identifiers: Product ID 62332-241_ad98d74c-5ee4-4bd5-9038-7b76a3ef4ad4SPL ID ad98d74c-5ee4-4bd5-9038-7b76a3ef4ad4
Pharmacologic class: P2Y12 Platelet Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332024130 followed by a unit qualifier and the quantity

Package 62332-0241-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 62332-241

What is NDC 62332-241?: 62332-241 is the product NDC for Ticagrelor, Ticagrelor 90 mg/1 tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ticagrelor.
What is the active ingredient?: Ticagrelor.
Who is the labeler?: Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ticagrelor?: 51 other product NDCs are listed under this name. See all Ticagrelor NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ticagrelor NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	Laurus Labs Limited	42385-993	42385-0993-0142385-0993-0542385-0993-11+4 more
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	Laurus Labs Limited	42385-994	42385-0994-0142385-0994-0542385-0994-11+4 more
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-940	72603-0940-01
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-941	72603-0941-0172603-0941-02
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-157	11788-0157-60
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-158	11788-0158-0111788-0158-60
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	American Health Packaging	60687-935	60687-0935-21
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	Lifestar Pharma LLC	70756-047	70756-0047-60
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	Lifestar Pharma LLC	70756-048	70756-0048-6070756-0048-99
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	American Health Packaging	60687-928	60687-0928-57

All 52 Ticagrelor NDCs

Other NDCs under ANDA 208576

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208576
Product	Strength	Form · route	Labeler	Product NDC
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-241
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-500
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-500
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	Redpharm Drug	67296-2268